Iqvia Holdings (IQV) Consolidated Net Income (2012 - 2026)
Iqvia Holdings' (IQV) quarterly Consolidated Net Income came in at $241.0 million in Q2 2026, down 9.74% year-over-year from $267.0 million in Q2 2025, and down 10.41% quarter-over-quarter from $269.0 million in Q1 2026.
Analysis
Iqvia Holdings (IQV) Consolidated Net Income (2012 - 2026) Analysis & Trends
Iqvia Holdings has disclosed Consolidated Net Income across 15 years of filings, most recently posting $241.0 million for Q2 2026.
- In Q2 2026, Consolidated Net Income fell 9.74% year-over-year to $241.0 million; the TTM figure through Jun 2026 stood at $1.3 billion (up 6.02% YoY), while the FY2025 annual figure was $1.3 billion, down 2.12% from the prior year.
- Consolidated Net Income came in at $241.0 million for Q2 2026 at Iqvia Holdings, down from $269.0 million in the prior quarter.
- In the past five years, Consolidated Net Income ranged from a high of $478.0 million in Q4 2025 to a low of $227.0 million in Q4 2022.
- Average Consolidated Net Income over 5 years is $315.4 million, with a median of $291.0 million recorded in 2023.
- Year-over-year, Consolidated Net Income slipped 28.39% in 2022 and surged 109.25% in 2023.
- Over 5 years, Consolidated Net Income stood at $227.0 million in 2022, then surged by 109.25% to $475.0 million in 2023, then retreated by 9.05% to $432.0 million in 2024, then climbed by 10.65% to $478.0 million in 2025, then slumped by 49.58% to $241.0 million in 2026.
- Per Business Quant data, the three most recent Consolidated Net Income figures were $241.0 million in Q2 2026, $269.0 million in Q1 2026, and $478.0 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 241.00 Mn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 121.36 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 111.81 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | -760,000.00 |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | -13.20 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | -46.71 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | -426,000.00 |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | -4.28 Bn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | -2.74 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 241.00 Mn |
| Mar 31, 2026 | 269.00 Mn |
| Dec 31, 2025 | 478.00 Mn |
| Sep 30, 2025 | 332.00 Mn |
| Jun 30, 2025 | 267.00 Mn |
| Mar 31, 2025 | 262.00 Mn |
| Dec 31, 2024 | 432.00 Mn |
| Sep 30, 2024 | 284.00 Mn |
| Jun 30, 2024 | 361.00 Mn |
| Mar 31, 2024 | 291.00 Mn |
| Dec 31, 2023 | 475.00 Mn |
| Sep 30, 2023 | 298.00 Mn |
| Jun 30, 2023 | 294.00 Mn |
| Mar 31, 2023 | 291.00 Mn |
| Dec 31, 2022 | 227.00 Mn |
| Sep 30, 2022 | 290.00 Mn |
| Jun 30, 2022 | 257.00 Mn |
| Mar 31, 2022 | 329.00 Mn |
| Dec 31, 2021 | 317.00 Mn |
| Sep 30, 2021 | 261.00 Mn |